Italia markets close in 4 hours 50 minutes
FTSE MIB
27.037,30 +298,29 (+1,12%) Dow Jones
32.717,60 +323,35 (+1,00%) Nasdaq
11.926,24 +210,16 (+1,79%) Nikkei 225
27.782,93 -100,85 (-0,36%) Petrolio
73,66 +0,69 (+0,95%) Bitcoin EUR
26.253,72 +114,57 (+0,44%)
bluebird bio, Inc. (BLUE)
NasdaqGS - NasdaqGS Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
Alla chiusura: 04:00PM EDT
Preborsa:
| Chiusura precedente | 4,3200 |
| Aperto | 3,6800 |
| Denaro | 0,0000 x 3100 |
| Lettera | 0,0000 x 2200 |
| Min-Max giorno | 2,9501 - 3,7400 |
| Intervallo di 52 settimane | 2,8700 - 8,5800 |
| Volume | |
| Media Volume | 4.177.123 |
| Capitalizzazione | 335,529M |
| Beta (5 anni mensile) | N/D |
| Rapporto PE (ttm) | N/D |
| EPS (ttm) | -5,6700 |
| Prossima data utili | 08 mag 2023 - 12 mag 2023 |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 7,60 |
- GlobeNewswire
Real Endpoints Marketplace announces collaboration with bluebird bio to help scale delivery of a first-of-its-kind value-based contract for one-time gene therapy
The risk-sharing agreement removes economic uncertainties, enabling regional and mid-sized health plans to provide patients with transfusion-dependent beta-thalassemia access to ZYNTEGLOFLORHAM PARK, N.J., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Real Endpoints, the leading market-access platform and advisory firm, announced a collaboration with bluebird bio, inc. (Nasdaq: BLUE), to provide multiple health plans with access to an innovative, outcomes-based agreement for ZYNTEGLO® (betibeglogene autotem
© 2023 Yahoo. Tutti i diritti riservati.
